Medtronic touts a real-world study of its Reveal Linq insertable cardiac monitor for detecting atrial fibrillation and says a separate analysis shows that long-term implanted cardiac monitoring is cost-effective.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1KMcQGJ
Cap comentari:
Publica un comentari a l'entrada